Lacidofil
Sponsors
Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy, Dr. Stephen Freedman, Indonesia University, Lallemand Health Solutions, National Health Insurance Service Ilsan Hospital
Conditions
DiarrheaGastroenteritisHelicobacter Pylori InfectionInfluenza-like IllnessMultiple sclerosisPneumoniaProbiotics
Phase 2
Efficacy and Safety of Lacidofil® STRONG as an Adjuvant for Helicobacter Pylori Treatment in Non-ulcer Dyspepsia
CompletedNCT04473079
Start: 2020-10-16End: 2022-06-17Updated: 2024-04-17
PRObiotic Therapy Examining Combinatorial Therapeutics in Multiple Sclerosis - phase II, multicenter, randomised, open-label clinical trial.
WithdrawnCTIS2025-520955-10-00
Target: 210Updated: 2025-10-20
Phase 3
Phase 4
Probiotic and Influenza Vaccination to Reducing Influenza-like Illness Incident in Elderly
CompletedNCT03695432
Start: 2014-10-31End: 2016-07-31Updated: 2018-10-05
Impact of Probiotics on Antibiotic-associated Diarrhea in Community-acquired Pneumonia
Not yet recruitingNCT06990568
Start: 2025-06-01End: 2026-12-31Target: 100Updated: 2025-05-25